Premedication Gastric Ultrasound

StatusEnrolling by Invitation
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Dec 2026 → Dec 2027
See other at-risk trials from Kevin Spellman

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Primary and study completion pushed from Dec 2026 to Dec 2027
    • Site details revised
    • Eligibility criteria expanded, about 2 words
  3. Lead sponsor: Alok Moharir to Kevin Spellman
    • Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 1
    • Start date changed from estimate of May 2025 to Aug 18, 2025
    v14
  4. Primary and study completion dates: Dec 2025 to Dec 2026
    • Start date: Sep 2024 to May 2025
    v13
  5. Start date: Jun 2024 to Sep 2024v12
Show 10 earlier versionsHide 10 earlier versions
  1. Primary and study completion dates: Dec 2024 to Dec 2025
    • Start date: Jan 2024 to Jun 2024
    v11
  2. Start date: Jun 2023 to Jan 2024v10
  3. Lead sponsor: Ajay D'Mello to Alok Moharir
    • Primary and study completion dates: Dec 2022 to Dec 2024
    • Start date: Jun 2022 to Jun 2023
    v9
  4. Lead sponsor: Vidya Raman to Ajay D'Mello
    • Start date: Nov 2021 to Jun 2022
    v8
  5. Start date: Jun 2021 to Nov 2021v7
  6. Primary and study completion dates: Dec 2021 to Dec 2022
    • Start date: Oct 2020 to Jun 2021
    v6
  7. Primary and study completion dates: Sep 2020 to Dec 2021
    • Start date: May 2020 to Oct 2020
    v5
  8. Start date: Feb 2020 to May 2020
    • Primary and study completion dates: May 2020 to Sep 2020
    v4
  9. Start date: Dec 2019 to Feb 2020v3
  10. Start date: Oct 2019 to Dec 2019v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The primary objective of this study is to assess gastric volume in fasted children using ultrasound before and after drinking premedication. The hypothesis is that the qualitative and quantitative assessment by gastric ultrasound in the stomach before and after drinking premedication will be the same as premedication has a small volume.
Trial Details
NCT Number NCT04130022
Lead Sponsor Kevin Spellman
Conditions
(from sponsor)		 Surgery
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov